Literature DB >> 27363708

[Histological grading of breast cancer].

M Christgen1, F Länger2, H Kreipe2.   

Abstract

From a historical perspective, histological grading was the earliest cell-based method for assessing tumor biology and the prognosis of breast cancer. This review article provides detailed and practical instructions for grading of breast cancer in routine diagnostics. Furthermore, the increasing relevance of precise histological grading in the era of molecular pathology is discussed.

Entities:  

Keywords:  Mitotic activity; Nuclear pleomorphism; Prognosis; Tubule formation; Tumor biology

Mesh:

Substances:

Year:  2016        PMID: 27363708     DOI: 10.1007/s00292-016-0182-8

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  36 in total

1.  Proposal for a modified grading system based on mitotic index and Bcl2 provides objective determination of clinical outcome for patients with breast cancer.

Authors:  Tarek M A Abdel-Fatah; Desmond G Powe; Graham Ball; Maria A Lopez-Garcia; Hany O Habashy; Andrew R Green; Jorge S Reis-Filho; Ian O Ellis
Journal:  J Pathol       Date:  2010-12       Impact factor: 7.996

2.  Interobserver agreement and reproducibility in classification of invasive breast carcinoma: an NCI breast cancer family registry study.

Authors:  Teri A Longacre; Marguerite Ennis; Louise A Quenneville; Anita L Bane; Ira J Bleiweiss; Beverley A Carter; Edison Catelano; Michael R Hendrickson; Hanina Hibshoosh; Lester J Layfield; Lorenzo Memeo; Hong Wu; Frances P O'malley
Journal:  Mod Pathol       Date:  2006-02       Impact factor: 7.842

3.  An international study to increase concordance in Ki67 scoring.

Authors:  Mei-Yin C Polley; Samuel C Y Leung; Dongxia Gao; Mauro G Mastropasqua; Lila A Zabaglo; John M S Bartlett; Lisa M McShane; Rebecca A Enos; Sunil S Badve; Anita L Bane; Signe Borgquist; Susan Fineberg; Ming-Gang Lin; Allen M Gown; Dorthe Grabau; Carolina Gutierrez; Judith C Hugh; Takuya Moriya; Yasuyo Ohi; C Kent Osborne; Frédérique M Penault-Llorca; Tammy Piper; Peggy L Porter; Takashi Sakatani; Roberto Salgado; Jane Starczynski; Anne-Vibeke Lænkholm; Giuseppe Viale; Mitch Dowsett; Daniel F Hayes; Torsten O Nielsen
Journal:  Mod Pathol       Date:  2015-02-20       Impact factor: 7.842

4.  A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer.

Authors:  Soonmyung Paik; Steven Shak; Gong Tang; Chungyeul Kim; Joffre Baker; Maureen Cronin; Frederick L Baehner; Michael G Walker; Drew Watson; Taesung Park; William Hiller; Edwin R Fisher; D Lawrence Wickerham; John Bryant; Norman Wolmark
Journal:  N Engl J Med       Date:  2004-12-10       Impact factor: 91.245

5.  The region-of-interest size impacts on Ki67 quantification by computer-assisted image analysis in breast cancer.

Authors:  Matthias Christgen; Sabrina von Ahsen; Henriette Christgen; Florian Länger; Hans Kreipe
Journal:  Hum Pathol       Date:  2015-05-30       Impact factor: 3.466

6.  [Morphological response to therapy of breast carcinoma].

Authors:  F Länger; H-J Lück; H H Kreipe
Journal:  Pathologe       Date:  2004-11       Impact factor: 1.011

7.  Histologic grading of breast carcinoma. A reproducibility study.

Authors:  L W Dalton; D L Page; W D Dupont
Journal:  Cancer       Date:  1994-06-01       Impact factor: 6.860

Review 8.  Histological and molecular types of breast cancer: is there a unifying taxonomy?

Authors:  Britta Weigelt; Jorge S Reis-Filho
Journal:  Nat Rev Clin Oncol       Date:  2009-12       Impact factor: 66.675

9.  Histologic grading is an independent prognostic factor in invasive lobular carcinoma of the breast.

Authors:  Emad A Rakha; Maysa E El-Sayed; Sindhu Menon; Andrew R Green; Andrew H S Lee; Ian O Ellis
Journal:  Breast Cancer Res Treat       Date:  2007-10-11       Impact factor: 4.872

10.  Histological grade concordance between diagnostic core biopsy and corresponding surgical specimen in HR-positive/HER2-negative breast carcinoma.

Authors:  C Daveau; S Baulies; M Lalloum; M Bollet; B Sigal-Zafrani; X Sastre; A Vincent-Salomon; A Tardivon; F Thibault; J Y Pierga; P Cottu; M P Sablin; R Rouzier; C Malhaire; P Mallon; F Reyal
Journal:  Br J Cancer       Date:  2014-04-08       Impact factor: 7.640

View more
  7 in total

1.  Ki-67 expression in pulmonary tumors-reply.

Authors:  Mark Kriegsmann; Arne Warth
Journal:  Transl Lung Cancer Res       Date:  2016-10

2.  BM-Net: CNN-Based MobileNet-V3 and Bilinear Structure for Breast Cancer Detection in Whole Slide Images.

Authors:  Jin Huang; Liye Mei; Mengping Long; Yiqiang Liu; Wei Sun; Xiaoxiao Li; Hui Shen; Fuling Zhou; Xiaolan Ruan; Du Wang; Shu Wang; Taobo Hu; Cheng Lei
Journal:  Bioengineering (Basel)       Date:  2022-06-20

3.  Microrna-136 promotes proliferation and invasion ingastric cancer cells through Pten/Akt/P-Akt signaling pathway.

Authors:  Xuyan Chen; Zhiming Huang; Renpin Chen
Journal:  Oncol Lett       Date:  2018-01-24       Impact factor: 2.967

4.  RILPL2 regulates breast cancer proliferation, metastasis, and chemoresistance via the TUBB3/PTEN pathway.

Authors:  Guanglei Chen; Lisha Sun; Jianjun Han; Sufang Shi; Yuna Dai; Weiguang Liu
Journal:  Am J Cancer Res       Date:  2019-08-01       Impact factor: 6.166

5.  Tumor tissue protein signatures reflect histological grade of breast cancer.

Authors:  Petter Skoog; Mattias Ohlsson; Mårten Fernö; Lisa Rydén; Carl A K Borrebaeck; Christer Wingren
Journal:  PLoS One       Date:  2017-06-26       Impact factor: 3.240

6.  TUFT1 is expressed in breast cancer and involved in cancer cell proliferation and survival.

Authors:  Weiguang Liu; Lei Zhang; Zining Jin; Min Zhao; Zhan Li; Guanglei Chen; Lisha Sun; Bo Chen
Journal:  Oncotarget       Date:  2017-08-24

7.  High peroxidasin-like expression is a potential and independent prognostic biomarker in breast cancer.

Authors:  Yanqing Li; Yan Jiao; Zhangping Luo; Yang Li; Yanan Liu
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.